Removal of dsRNA byproducts using affinity chromatography

Double-stranded RNA (dsRNA) molecules are immunogenic byproducts of <i>in vitro</i> transcription of single-stranded RNA (ssRNA). Removal of dsRNA from ssRNA is difficult because the byproducts have similar sizes, sequences, and charges to the desired ssRNA. Here, we describe a dsRNA-specific affinity resin that selectively removes dsRNA from ssRNA. Affinity purification reduced dsRNA levels by >100-fold, to as low as ∼0.00007% w/w of total mRNA, with no negative impact on RNA integrity. The purified RNA, synthesized with standard nucleotides, induced no inflammatory response in a reporter cell line assay designed to measure innate immune responses. Purified RNA induced greater protein expression and healthier cells. The immunogenicity of the affinity-purified RNA with standard nucleotides compares favorably to RNA synthesized with modified nucleotides and purified with cellulose or reverse-phase high-performance liquid chromatography (HPLC). dsRNA affinity purification provides a facile and scalable solution to the problem of immunogenic dsRNA byproducts in transcribed RNA. This approach will improve quality and safety of RNA vaccines and therapeutics.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2025-04-29
DOI
https://doi.org/10.1016/j.omtn.2025.102549
Citations
8
Primary Topic
RNA regulation and disease
Type
article
Field-Weighted Citation Impact
6.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Removal of dsRNA byproducts using affinity chromatography

Kelley Kearns, Thomas C. Scanlon, Nathaniel E. Clark, Roger A. Winters et al.
8 citations
Molecular Therapy — Nucleic Acids
RNA regulation and disease
6.45
article

Removal of dsRNA byproducts using affinity chromatography

Kelley Kearns, Thomas C. Scanlon, Nathaniel E. Clark, Roger A. Winters, J. van den Heuvel, Mateusz Kozarski, Sinem Demirel Asci, Matt R Schraut, Senne Dillen
article en
8 citations

Abstract

Double-stranded RNA (dsRNA) molecules are immunogenic byproducts of <i>in vitro</i> transcription of single-stranded RNA (ssRNA). Removal of dsRNA from ssRNA is difficult because the byproducts have similar sizes, sequences, and charges to the desired ssRNA. Here, we describe a dsRNA-specific affinity resin that selectively removes dsRNA from ssRNA. Affinity purification reduced dsRNA levels by >100-fold, to as low as ∼0.00007% w/w of total mRNA, with no negative impact on RNA integrity. The purified RNA, synthesized with standard nucleotides, induced no inflammatory response in a reporter cell line assay designed to measure innate immune responses. Purified RNA induced greater protein expression and healthier cells. The immunogenicity of the affinity-purified RNA with standard nucleotides compares favorably to RNA synthesized with modified nucleotides and purified with cellulose or reverse-phase high-performance liquid chromatography (HPLC). dsRNA affinity purification provides a facile and scalable solution to the problem of immunogenic dsRNA byproducts in transcribed RNA. This approach will improve quality and safety of RNA vaccines and therapeutics.

Molecular Therapy — Nucleic AcidsVol. 36(2)
Galapagos (Belgium) (BE), Repligen (United States) (US)
Openalex Percentile: Top 3%
RNA regulation and disease
6.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Removal of dsRNA byproducts using affinity chromatography — Kelley Kearns, Thomas C. Scanlon, et al. · Molecular Therapy — Nucleic Acids (2025) | TGRS Research Map | TGRS